BetterLife Pharma Inc C.BETR

Alternate Symbol(s): BETRF

Healthcare

BetterLife Pharma Inc. is a biotechnology company. The Company is primarily focused on developing and commercializing two compounds, BETR-001 and BETR-002, to treat neuro-psychiatric and neurological disorders. BETR-001, which is in preclinical and is a non-hallucinogenic and non- controlled lysergic acid diethylamide (LSD) derivative in development and that is unregulated and therefore can be self-administered. Its synthesis patent for BETR-001 eliminates regulatory hurdles and its pending patent, for composition and method of use, covers treatment of major depressive disorder, anxiety disorder and neuropathic pain and other neuro-psychiatric and neurological disorders. BETR-002, which is in preclinical and is based on honokiol, the active anxiolytic ingredient of magnolia bark. Its pending method of use and formulations patent covers treatment of anxiety related disorders including benzodiazepine dependency. It also owns a drug candidate for the treatment of viral infections.

CSE:BETR - Post by User

BetterLife Pharma Inc > CATEGORY 5 HURRICANE (BETR) -ABOUT TO MAKE LANDFALL-

<< Previous

Bullboard Posts

Next >>

Comment by MustangSalleyon Nov 03, 2021 9:09pm

322 Views

Post# 34084917

RE:CATEGORY 5 HURRICANE (BETR) -ABOUT TO MAKE LANDFALL-

ErikD ,

Yeah hurrricane about to hit but the other way around.

Great volume lately , with catalysts and data coming could be a dark horse.

way undervalued for the potential and indications for markets such as depression, anxiety and cluster headache ( no viable treatment in multibillions dollar market) .

Lets see what happens EriKD ...don't hold your breath.

Ms Sally

<< Previous

Bullboard Posts

Next >>

Two micro-cap stocks with strong fundamentals